Comparison of the cost-effectiveness of sequential treatment with abaloparatide in US men and women at very high risk of fractures

被引：0
|
作者：
Mickael Hiligsmann
Stuart L. Silverman
Andrea J. Singer
Leny Pearman
Yamei Wang
John Caminis
Jean-Yves Reginster
机构：
[1] CAPHRI Care and Public Health Research Institute,Department of Health Services Research
[2] Maastricht University,Cedars
[3] Los Angeles and the OMC Clinical Research Center,Sinai Medical Center
[4] MedStar Georgetown University Hospital and Georgetown University Medical Center,Division of Public Health, Epidemiology and Health Economics
[5] Radius Health,undefined
[6] Inc.,undefined
[7] University of Liège,undefined
[8] World Health Organization Collaborating Center for Epidemiology of Musculoskeletal Health and Aging,undefined
来源：
Aging Clinical and Experimental Research | / 36卷
关键词：
Abaloparatide; Alendronate; Cost-effectiveness; Gender; Osteoporosis; Sequential;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Comparison of the cost-effectiveness of sequential treatment with abaloparatide in US men and women at very high risk of fractures
    Hiligsmann, Mickael
    Silverman, Stuart L.
    Singer, Andrea J.
    Pearman, Leny
    Wang, Yamei
    Caminis, John
    Reginster, Jean-Yves
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2024, 36 (01)
  • [2] COST-EFFECTIVENESS OF ABALOPARATIDE FOLLOWED BY ALENDRONATE IN US WOMEN AND MEN AT HIGH RISK OF OSTEOPOROTIC FRACTURES
    Hiligsmann, M.
    Silverman, S.
    Singer, A. J.
    Pearman, L.
    Wang, Y.
    Caminis, J.
    Reginster, J. Y.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2023, 35 : S55 - S55
  • [3] Cost-Effectiveness of Sequential Treatment with Abaloparatide Followed by Alendronate in US Men at High Risk of Fracture
    Hiligsmann, Mickael
    Silverman, Stuart
    Singer, Andrea J.
    Pearman, Leny
    Mathew, Jake
    Wang, Yamei
    Caminis, John
    Reginster, Jean-Yves
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 2582 - 2583
  • [4] COMPARISON OF THE COST-EFFECTIVENESS OF SEQUENTIAL TREATMENT WITH ABALOPARATIDE FOLLOWED BY ALENDRONATE BETWEEN US WOMEN AND MEN AT INCREASED RISK OF FRACTURE
    Hiligsmann, M.
    Silverman, S.
    Singer, A. J.
    Pearman, L.
    Wang, Y.
    Caminis, J.
    Reginster, J. Y.
    VALUE IN HEALTH, 2023, 26 (06) : S84 - S84
  • [5] Cost-Effectiveness Analysis of Sequential Treatment with Abaloparatide Followed by Alendronate in US Women and Men with Multiple Previous Fractures
    Hiligsmann, Mickael
    Silverman, Stuart
    Singer, Andrea J.
    Wang, Yamei
    Pearman, Leny
    Caminis, John
    Reginster, Jean-Yves
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 3970 - 3971
  • [6] Cost-Effectiveness of Sequential Abaloparatide/Alendronate in Men at High Risk of Fractures in the United States
    Mickaël Hiligsmann
    Stuart S. Silverman
    Andrea J. Singer
    Leny Pearman
    Jake Mathew
    Yamei Wang
    John Caminis
    Jean-Yves Reginster
    PharmacoEconomics, 2023, 41 : 819 - 830
  • [7] Cost-Effectiveness of Sequential Abaloparatide/Alendronate in Men at High Risk of Fractures in the United States
    Hiligsmann, Mickael
    Silverman, Stuart S.
    Singer, Andrea J.
    Pearman, Leny
    Mathew, Jake
    Wang, Yamei
    Caminis, John
    Reginster, Jean-Yves
    PHARMACOECONOMICS, 2023, 41 (07) : 819 - 830
  • [8] Cost-Effectiveness of Sequential Abaloparatide/Alendronate for US Women and Men at Very High Risk of Fracture: an Economic Evaluation Based on Network Meta-Analysis
    Hiligsmann, Mickael
    Silverman, Stuart
    Singer, Andrea
    Pearman, Leny
    Wang, Yamei
    Caminis, John
    Reginster, Jean-Yves
    JOURNAL OF BONE AND MINERAL RESEARCH, 2023, 38 : 184 - 184
  • [9] Cost-Effectiveness of Sequential Abaloparatide/Alendronate for US Women and Men With Osteoporosis and a Recent Vertebral Fracture
    Hiligsmann, Mickael
    Silverman, Stuart
    Singer, Andrea J.
    Pearman, Leny
    Wang, Yamei
    Caminis, John
    Reginster, Jean-Yves
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2023, 30 (12): : 1257 - 1258
  • [10] COST-EFFECTIVENESS OF SEQUENTIAL TREATMENT WITH ABALOPARATIDE VS. TERIPARATIDE FOR THE PREVENTION OF OSTEOPOROTIC FRACTURES IN POSTMENOPAUSAL US WOMEN AT INCREASED RISK OF FRACTURE
    Hiligsmann, M.
    Williams, S. A.
    Fitzpatrick, L. A.
    Silverman, S.
    Weiss, R.
    Reginster, J. -Y.
    OSTEOPOROSIS INTERNATIONAL, 2018, 29 : S314 - S314
12345